State of Wisconsin Investment Board
CYCN icon

State of Wisconsin Investment Board’s Cyclerion Therapeutics CYCN Stock Holding History

State of Wisconsin Investment Board’s Portfolio CYCN Stock Details CYCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,774
Closed -$96K – 1706
2019
Q4 		$96K Hold
1,774
– – ﹤0.01% 1609
2019
Q3 		$430K Buy
1,774
+835
+89% +$180K ﹤0.01% 1375
2019
Q2 		$215K Buy
+939
New +$266K ﹤0.01% 1481

Other funds holding CYCN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

State of Wisconsin Investment Board's CYCN Position: Q1 2020 in Review

State of Wisconsin Investment Board sold out of Cyclerion Therapeutics (CYCN) in Q1 2020, closing a stake of 1,774 shares — an estimated $96K sold.

State of Wisconsin Investment Board first reported a position in CYCN in Q2 2019 and held it in 3 quarters. The position peaked at $430K in Q3 2019. 80 funds tracked by Wall St. Rank hold CYCN as of Q1 2020.

  • State of Wisconsin Investment Board reported no remaining Cyclerion Therapeutics position as of Q1 2020 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 1,774 Cyclerion Therapeutics shares in Q1 2020, an estimated $96K.
  • State of Wisconsin Investment Board first reported a position in Cyclerion Therapeutics in Q2 2019 and held it in 3 quarters.
  • State of Wisconsin Investment Board's Cyclerion Therapeutics position peaked at $430K in Q3 2019.
  • 80 funds tracked by Wall St. Rank held Cyclerion Therapeutics as of Q1 2020.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2020, filed 6 May 2020.